SE8100829L - Sett att framstella 17beta-hydroxi-4-androsten-3-oner - Google Patents

Sett att framstella 17beta-hydroxi-4-androsten-3-oner

Info

Publication number
SE8100829L
SE8100829L SE8100829A SE8100829A SE8100829L SE 8100829 L SE8100829 L SE 8100829L SE 8100829 A SE8100829 A SE 8100829A SE 8100829 A SE8100829 A SE 8100829A SE 8100829 L SE8100829 L SE 8100829L
Authority
SE
Sweden
Prior art keywords
hydroxy
androsten
oner
17beta
make
Prior art date
Application number
SE8100829A
Other languages
English (en)
Inventor
R Wiechert
D Bittler
U Kerb
J Casals-Stenzel
W Losert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772722705 external-priority patent/DE2722705A1/de
Priority claimed from DE19772722706 external-priority patent/DE2722706A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE8100829L publication Critical patent/SE8100829L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (1)

Patentkrav
1. Sgtt att framstglla 17p-hydroxi-g-androsten-3-oner med den allmdnna formeln IOH M3 2 0 (CH2)3-OR2 1112 dgr 12 betecknar vgte eller en organisk syrarest med upp till 8 kolatomer,kgnnetecknatam att man pgioch for sig kgnt sgtt omsgtter en 3-keto-H,5-androstadien-spirolakton med formeln III 0 II CH2
SE8100829A 1977-05-16 1981-02-05 Sett att framstella 17beta-hydroxi-4-androsten-3-oner SE8100829L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19772722705 DE2722705A1 (de) 1977-05-16 1977-05-16 Androsta-4.15-dien-3-one und verfahren zu ihrer herstellung
DE19772722706 DE2722706A1 (de) 1977-05-16 1977-05-16 15.16-methylen-androsta-4.15-dien- 3-one und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
SE8100829L true SE8100829L (sv) 1981-02-05

Family

ID=25772043

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7805413A SE433356B (sv) 1977-05-16 1978-05-11 Sett att framstella 17beta-hydroxi-4-androsten-3-oner
SE8100829A SE8100829L (sv) 1977-05-16 1981-02-05 Sett att framstella 17beta-hydroxi-4-androsten-3-oner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7805413A SE433356B (sv) 1977-05-16 1978-05-11 Sett att framstella 17beta-hydroxi-4-androsten-3-oner

Country Status (21)

Country Link
US (1) US4180570A (sv)
JP (1) JPS53141258A (sv)
AT (1) AT360676B (sv)
AU (1) AU515595B2 (sv)
CA (1) CA1105004A (sv)
CH (1) CH639105A5 (sv)
CS (1) CS200235B2 (sv)
DD (1) DD135497A5 (sv)
DK (1) DK147406C (sv)
ES (1) ES469510A1 (sv)
FR (1) FR2391224A1 (sv)
GB (1) GB1602986A (sv)
GR (1) GR71590B (sv)
HU (1) HU179345B (sv)
IE (1) IE46896B1 (sv)
IL (1) IL54718A (sv)
IT (1) IT1094627B (sv)
LU (1) LU79652A1 (sv)
NL (1) NL7805114A (sv)
SE (2) SE433356B (sv)
SU (1) SU786905A3 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2922500A1 (de) * 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta
DE3130644A1 (de) * 1981-07-29 1983-02-17 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue androstan-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
JPS5921698A (ja) * 1982-07-22 1984-02-03 シエ−リング・アクチエンゲゼルシヤフト １７α−プレグネ−４−エン−３−オキソ−２１−カルボン酸エステル、その製法およびこれを含有する抗アンドロゲン作用を有する医薬
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene
JPS6248694A (ja) * 1985-08-28 1987-03-03 Shionogi & Co Ltd 抗アルドステロン活性ステロイド誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH609357A5 (sv) * 1973-05-25 1979-02-28 Schering Ag
DE2439082A1 (de) * 1974-08-12 1976-02-26 Schering Ag 17 alpha-hydroxy-1,3,5(10),15-oestratetraene und verfahren zu ihrer herstellung
CH631462A5 (de) * 1976-03-05 1982-08-13 Schering Ag Verfahren zur herstellung von neuen steroiden der androstan- oder oestranreihe.

Also Published As

Publication number Publication date
AT360676B (de) 1981-01-26
DK213878A (da) 1978-11-17
DK147406B (da) 1984-07-23
FR2391224A1 (fr) 1978-12-15
CH639105A5 (de) 1983-10-31
US4180570A (en) 1979-12-25
LU79652A1 (de) 1978-11-06
GR71590B (sv) 1983-06-17
IL54718A0 (en) 1978-07-31
FR2391224B1 (sv) 1980-06-13
SE433356B (sv) 1984-05-21
ES469510A1 (es) 1978-12-01
GB1602986A (en) 1981-11-18
CS200235B2 (en) 1980-08-29
IE780977L (en) 1978-11-16
IT1094627B (it) 1985-08-02
DK147406C (da) 1985-02-11
CA1105004A (en) 1981-07-14
IL54718A (en) 1982-08-31
IE46896B1 (en) 1983-10-19
IT7823392A0 (it) 1978-05-15
DD135497A5 (de) 1979-05-09
SU786905A3 (ru) 1980-12-07
AU3615578A (en) 1979-11-22
AU515595B2 (en) 1981-04-09
ATA348378A (de) 1980-06-15
SE7805413L (sv) 1978-11-17
JPS53141258A (en) 1978-12-08
HU179345B (en) 1982-10-28
NL7805114A (nl) 1978-11-20

Similar Documents

Publication Publication Date Title
ES8100261A1 (es) Un procedimiento para la preparacion de un indol
GR69233B (sv)
SE7905402L (sv) Fenyl-piperazinderivat
IE45576L (en) Analgesic tetrapeptides and pentapeptides
IE791713L (en) Imidazolyl vinyl ethers
SE8100829L (sv) Sett att framstella 17beta-hydroxi-4-androsten-3-oner
SE7605361L (sv) Sett att framstella nya n-substituerade fenylpiperazinderivat
SE7704616L (sv) Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat
ES477785A1 (es) Procedimiento para la preparacion de nuevas 2-fenilimino- imidazolidinas sustituidas.
ATE27817T1 (de) Phenylpiperazin-derivate und verfahren zu deren herstellung.
ES353213A1 (es) Procedimiento para la produccion de derivados de dibenzo- tiazepina.
SE8006953L (sv) Heterocykliska foreningar
ATE14428T1 (de) Verfahren zur herstellung von bromhaltigen 1,3dioxolen-2-ones.
ATE85054T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
NO792389L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylamino-imidazolin-derivater
ES479122A1 (es) Procedimiento para la obtencion de preparados de accion diu-retica para administracion parenteral.
ES463797A1 (es) Procedimiento para la preparacion de o-(2-hidroxipropil)- aldoximas sustituidas con radicales basicos
ATE63550T1 (de) Neue 1-/ 3-(2-dialkylaminoaethoxy)-2-thienyl/-3phenyl-1-propanone und ihre saeureadditionssalze und verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
SE9000420L (sv) Foerfarande foer framstaellning av n,n-disubstituerade mandelsyraamider
ES8306150A1 (es) Procedimiento de preparacion de derivados halogenados de la vincamina.
ES8302734A1 (es) Procedimiento para preparar 5'-n-(aminoalquil)-amino-5'-deo-xiadenosina
ZA794692B (en) Diuretic compositions
ES467519A1 (es) Un procedimiento de preparacion de acidos furoil- o tenoil- naftiloxialcohilcarboxilicos.
ES485392A1 (es) Un procedimiento para la preparacion de derivados de amino- alcoholes.
IE780742L (en) Isoxazolylmethyl-benzomorphanes

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8100829-4

Format of ref document f/p: F